Clinical Trials Logo

Citation(s)

  •   Arnone D
    Review of the use of Topiramate for treatment of psychiatric disorders. Ann Gen Psychiatry. 2005 Feb 16;4(1):5.
  •   Berlant JL
    Prospective open-label study of add-on and monotherapy topiramate in civilians with chronic nonhallucinatory posttraumatic stress disorder. BMC Psychiatry. 2004 Aug 18;4:24.
  •   Blaszczynski A, Nower L
    A pathways model of problem and pathological gambling. Addiction. 2002 May;97(5):487-99. Review.
  •   Dannon PN, Lowengrub K, Gonopolski Y, Musin E, Kotler M
    Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study. Clin Neuropharmacol. 2005 Jan-Feb;28(1):6-10.
  •   Dannon PN
    Topiramate for the treatment of kleptomania: a case series and review of the literature. Clin Neuropharmacol. 2003 Jan-Feb;26(1):1-4. Review.
  •   Grant JE, Kim SW, Potenza MN
    Advances in the pharmacological treatment of pathological gambling. J Gambl Stud. 2003 Spring;19(1):85-109. Review.
  •   Johnson BA, Ait-Daoud N, Akhtar FZ, Ma JZ
    Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial. Arch Gen Psychiatry. 2004 Sep;61(9):905-12.
  •   Petry NM, Steinberg KL; Women's Problem Gambling Research Center
    Childhood maltreatment in male and female treatment-seeking pathological gamblers. Psychol Addict Behav. 2005 Jun;19(2):226-9.
  •   Steel Z, Blaszczynski A
    Impulsivity, personality disorders and pathological gambling severity. Addiction. 1998 Jun;93(6):895-905.

Clinical Assessment of Topiramate on Gambling-Related Behaviours in Problem Gamblers: Effects of Gender and Negative Emotionality

Details for clinical trial NCT00370188